Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGregori, S.-
dc.contributor.authorBacchetta, R.-
dc.contributor.authorHauben, E.-
dc.contributor.authorBattaglia, M.-
dc.contributor.authorRoncarolo, M.-
dc.identifier.citationCurrent Opinion in Hematology, 2005; 12(6):451-456-
dc.description.abstractPurpose of review: Regulatory T cells exert a dominant effect in controlling autoimmunity and maintaining peripheral tolerance. Regulatory T cells are also involved in preventing allograft rejection and graft versus host disease. Cellular therapy with expanded regulatory T cells represents a promising approach to control T-cell mediated pathology. In this review we will summarize the efforts to design new methods for expanding regulatory T cells and exploit their regulatory function as cellular therapy for the treatment of graft versus host disease after hematopoietic stem cell transplantation. Recent findings: Among CD4+ T cells, the best described are the naturally occurring CD4+CD25+ regulatory T cells and type 1 regulatory T cells. Recent progress has been made in the characterization of both subsets in terms of isolation and induction, respectively. However, a clear definition of their mechanisms of action has still to be achieved. Summary: Better understanding of the mechanisms of suppression mediated by regulatory T cells might enable their use to modulate specific immune responses. Moreover, the recent development of methods allowing the ex-vivo expansion of regulatory T cells, to provide sufficient number of cells for in-vivo infusion, represents the first step toward the use of these cells as cellular therapy for the treatment of immunologic and hematological diseases.-
dc.description.statementofresponsibilitySilvia Gregori, Rosa Bacchetta, Ehud Hauben, Manuela Battaglia and Maria-Grazia Roncarolo-
dc.publisherLippincott Williams & Wilkins-
dc.rights© 2005 Lippincott Williams & Wilkins, Inc.-
dc.subjectcellular therapy; CD4+CD25+; regulatory T cells; graft versus host disease; hematopoietic stem cell transplantation; type 1 regulatory T cells-
dc.titleRegulatory T cells: prospective for clinical application in hematopoietic stem cell transplantation-
dc.typeJournal article-
dc.identifier.orcidHauben, E. [0000-0002-6062-411X]-
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.